Powered by

Growing at an annualized rate of over 12%, the ADC contract manufacturing market is estimated to reach close to USD 3 Billion by 2030, claims Roots Analysis

Feb 04, 2021 - GlobeNewswire

London, Feb. 04, 2021 (GLOBE NEWSWIRE) -- has announced the addition of “” report to its list of offerings.

Manufacturing of an ADC therapeutic is known to be a capital intensive and technically demanding process. As a result, outsourcing has emerged as a viable business strategy in this domain. It is estimated that, presently, 70-80% of ADC manufacturing operations are outsourced, and the trend is likely to persist in the coming years, as well. Moreover, even the leading players i...